@Pseudoname1 MM always points to some negotiation so I don't think you could hang your hat on that being the case.
She stated that BIT was sharing and talking with other participants in the biotech sector - that is a long way from being a negotiation by definition.
I do agree that BIT should be investigating the general antiviral sector as a potential future development - but that would require a new trial series directed at that need - which is real.
That also will require considerable funds which BIT does not currently have.
Glad your little daughter is doing well. That would have been traumatic.
Apologies - reply tab not working.
@Pseudoname1 MM always points to some negotiation so I don't...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $6.301K | 317.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 811289 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1719463 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |